
STAMPing on BCR-ABL1: Asciminib Approved for Chronic Myeloid Leukemia
Author(s) -
Christine M. McMahon
Publication year - 2022
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v19.2.202221
Subject(s) - myeloid leukemia , medicine , leukemia , cancer research